MarketCapTrends
MYGN
Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare

Myriad Genetics Inc. Cash on Hand 2009–2025

Myriad Genetics Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Myriad Genetics Inc. cash on hand for the quarter ending December 31, 2025 were 149.6M, a 46.09% increase year-over-year.
  • Myriad Genetics Inc. cash on hand for 2025 were 149.6M, a 46.09% increase from 2024.
  • Myriad Genetics Inc. cash on hand for 2024 were 102.4M, a 22.48% decrease from 2023.
  • Myriad Genetics Inc. cash on hand for 2023 were 132.1M, a 132.16% increase from 2022.
  • Myriad Genetics Inc. cash on hand for 2022 were 56.9M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Myriad Genetics Inc. Annual Cash on Hand (Millions of US $)
2025$150
2024$102
2023$132
2022$57
2021$257
2020$117
2019$93
2018$111
2017$102
2016$69
2015$64
2014$65
2013$104
2012$86
2011$53
Myriad Genetics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$150
2024-12-31$102
2023-12-31$132
2022-12-31$57
2021-12-31$257
2020-12-31$117
2020-06-30$164
2019-06-30$93
2018-06-30$111
2017-06-30$102
2016-06-30$69
2015-06-30$64
2014-06-30$65
2013-06-30$104
2012-06-30$86
2011-06-30$53
2010-06-30$93

Myriad Genetics Inc. Cash on Hand — FAQ

Myriad Genetics Inc. (MYGN) cash on hand over the last 18 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MYGN's cash on hand history?

The chart and table above show Myriad Genetics Inc.'s cash on hand by year and by quarter, including the growth rate.